ANASTROZOLE
Clinical Indication
Off label chemoprevention to reduce incidence of breast cancer.
Comments
Use in line with NICE CG 164
Date of classification
June 2018
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .